ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

ONCC Says 1,480 Nurses Passed Certification Exam

January 6, 1989

Cancer Patient Medical history System Proposed

July 13, 1979

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

May 20, 1988

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

NIH Electronic Grant Coding System Worse Than NCI’s Manual Method, Advocates Say.

September 5, 2008

NCAB Orders 23 Unfunded Organ Site Grants Paid, Sends Contradictory Messages On Program Revisions

December 3, 1982